These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 24299225)

  • 1. Evaluation of a 5-day education programme in type 1 diabetes: achieving individual targets with a patient-centred approach.
    Halbron M; Sachon C; Simon D; Obadia T; Grimaldi A; Hartemann A
    Diabet Med; 2014 Apr; 31(4):500-3. PubMed ID: 24299225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of an education programme (MEDIAS 2 BSC) of non-intensive insulin treatment regimens for people with Type 2 diabetes: a randomized, multi-centre trial.
    Hermanns N; Ehrmann D; Schall S; Maier B; Haak T; Kulzer B
    Diabet Med; 2017 Aug; 34(8):1084-1091. PubMed ID: 28257159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a treatment and teaching refresher programme for the optimization of intensified insulin therapy in type 1 diabetes.
    Müller N; Kloos C; Sämann A; Wolf G; Müller UA
    Patient Educ Couns; 2013 Oct; 93(1):108-13. PubMed ID: 23747089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structured type 1 diabetes education delivered in routine care in Australia reduces diabetes-related emergencies and severe diabetes-related distress: The OzDAFNE program.
    Speight J; Holmes-Truscott E; Harvey DM; Hendrieckx C; Hagger VL; Harris SE; Knight BA; McIntyre HD
    Diabetes Res Clin Pract; 2016 Feb; 112():65-72. PubMed ID: 26688058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained benefit of continuous subcutaneous insulin infusion on glycaemic control and hypoglycaemia in adults with Type 1 diabetes.
    Beato-Víbora P; Yeoh E; Rogers H; Hopkins D; Amiel SA; Choudhary P
    Diabet Med; 2015 Nov; 32(11):1453-9. PubMed ID: 26213236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycaemic control and severe hypoglycaemia following training in flexible, intensive insulin therapy to enable dietary freedom in people with type 1 diabetes: a prospective implementation study.
    Sämann A; Mühlhauser I; Bender R; Kloos Ch; Müller UA
    Diabetologia; 2005 Oct; 48(10):1965-70. PubMed ID: 16132954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Tayside insulin management course: an effective education programme in type 1 diabetes.
    Jordan LV; Robertson M; Grant L; Peters RE; Cameron JT; Chisholm S; Voigt DJ; Matheson L; Kerr EJ; Maclean K; Macalpine RR; Wilson E; Mackie AD; Summers NM; Vadiveloo T; Leese GP
    Int J Clin Pract; 2013 May; 67(5):462-8. PubMed ID: 23510057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
    Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
    Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential of education-based insulin therapy for achievement of good metabolic control: a real-life experience.
    Albrecht D; Puder J; Keller U; Zulewski H
    Diabet Med; 2011 May; 28(5):539-42. PubMed ID: 21480964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial.
    Benhamou PY; Franc S; Reznik Y; Thivolet C; Schaepelynck P; Renard E; Guerci B; Chaillous L; Lukas-Croisier C; Jeandidier N; Hanaire H; Borot S; Doron M; Jallon P; Xhaard I; Melki V; Meyer L; Delemer B; Guillouche M; Schoumacker-Ley L; Farret A; Raccah D; Lablanche S; Joubert M; Penfornis A; Charpentier G;
    Lancet Digit Health; 2019 May; 1(1):e17-e25. PubMed ID: 33323237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Alimentación Normal con Ajuste de Insulina (ANAIS), a Spanish version of the DAFNE programme, in people with Type 1 diabetes: a randomized controlled parallel trial.
    Sánchez-Hernández RM; Alvarado-Martel D; López-Plasencia Y; Carrillo-Domínguez A; Jiménez-Rodríguez A; Rodríguez-Cordero J; Vera-Elzo T; Santana Del Pino Á; Nóvoa-Mogollón FJ; Wägner AM
    Diabet Med; 2019 Aug; 36(8):1037-1045. PubMed ID: 31087451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a holistic treatment and teaching programme for patients with Type 1 diabetes who failed to achieve their therapeutic goals under intensified insulin therapy.
    Bott U; Bott S; Hemmann D; Berger M
    Diabet Med; 2000 Sep; 17(9):635-43. PubMed ID: 11051282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Training in flexible intensive insulin therapy improves quality of life, decreases the risk of hypoglycaemia and ameliorates poor metabolic control in patients with type 1 diabetes.
    Bendik CF; Keller U; Moriconi N; Gessler A; Schindler Ch; Zulewski H; Ruiz J; Puder JJ
    Diabetes Res Clin Pract; 2009 Mar; 83(3):327-33. PubMed ID: 19128852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of insulin pump therapy on key parameters of diabetes management and diabetes related emotional distress in the first 12 months.
    Oldham V; Mumford B; Lee D; Jones J; Das G
    Diabetes Res Clin Pract; 2020 Aug; 166():108281. PubMed ID: 32628980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the SPECTRUM training programme for real-time continuous glucose monitoring: A real-world multicentre prospective study in 120 adults with type 1 diabetes.
    Schlüter S; Freckmann G; Heinemann L; Wintergerst P; Lange K
    Diabet Med; 2021 Feb; 38(2):e14467. PubMed ID: 33230860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: the REPOSE Trial.
    Heller S; White D; Lee E; Lawton J; Pollard D; Waugh N; Amiel S; Barnard K; Beckwith A; Brennan A; Campbell M; Cooper C; Dimairo M; Dixon S; Elliott J; Evans M; Green F; Hackney G; Hammond P; Hallowell N; Jaap A; Kennon B; Kirkham J; Lindsay R; Mansell P; Papaioannou D; Rankin D; Royle P; Smithson WH; Taylor C
    Health Technol Assess; 2017 Apr; 21(20):1-278. PubMed ID: 28440211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood glucose awareness training and epinephrine responses to hypoglycemia during intensive treatment in type 1 diabetes.
    Kinsley BT; Weinger K; Bajaj M; Levy CJ; Simonson DC; Quigley M; Cox DJ; Jacobson AM
    Diabetes Care; 1999 Jul; 22(7):1022-8. PubMed ID: 10388961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous subcutaneous insulin infusion (CSII) therapy at Derby Teaching Hospitals: sustained benefits in glucose control.
    Anyanwagu U; Olaoye H; Jennings P; Ashton-Cleary S; Sugunendran S; Hughes D; Idris I; Wilmot EG
    Diabet Med; 2017 Aug; 34(8):1154-1157. PubMed ID: 28430381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline HbA1c predicts attainment of 7.0% HbA1c target with structured titration of insulin glargine in type 2 diabetes: a patient-level analysis of 12 studies.
    Riddle MC; Vlajnic A; Zhou R; Rosenstock J
    Diabetes Obes Metab; 2013 Sep; 15(9):819-25. PubMed ID: 23489438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of exenatide QW or placebo, both added to titrated insulin glargine, in uncontrolled type 2 diabetes: The DURATION-7 randomized study.
    Guja C; Frías JP; Somogyi A; Jabbour S; Wang H; Hardy E; Rosenstock J
    Diabetes Obes Metab; 2018 Jul; 20(7):1602-1614. PubMed ID: 29473704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.